These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 27526622

  • 1. The Combined Usefulness of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Predicting Intravenous Immunoglobulin Resistance with Kawasaki Disease.
    Kawamura Y, Takeshita S, Kanai T, Yoshida Y, Nonoyama S.
    J Pediatr; 2016 Nov; 178():281-284.e1. PubMed ID: 27526622
    [Abstract] [Full Text] [Related]

  • 2. A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki disease.
    Takeshita S, Kanai T, Kawamura Y, Yoshida Y, Nonoyama S.
    PLoS One; 2017 Nov; 12(5):e0176957. PubMed ID: 28542183
    [Abstract] [Full Text] [Related]

  • 3. Value of neutrophil-lymphocyte ratio in predicting outcomes in Kawasaki disease.
    Ha KS, Lee J, Jang GY, Lee J, Lee KC, Son CS, Lee JW.
    Am J Cardiol; 2015 Jul 15; 116(2):301-6. PubMed ID: 25975725
    [Abstract] [Full Text] [Related]

  • 4. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
    Sato S, Kawashima H, Kashiwagi Y, Hoshika A.
    Int J Rheum Dis; 2013 Apr 15; 16(2):168-72. PubMed ID: 23773640
    [Abstract] [Full Text] [Related]

  • 5. Circulating platelet-neutrophil aggregates play a significant role in Kawasaki disease.
    Ueno K, Nomura Y, Morita Y, Eguchi T, Masuda K, Kawano Y.
    Circ J; 2015 Apr 15; 79(6):1349-56. PubMed ID: 25787672
    [Abstract] [Full Text] [Related]

  • 6. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
    Huang XB, Zhao S, Liu ZY, Xu YY, Deng F.
    Ann Med; 2023 Apr 15; 55(2):2264315. PubMed ID: 37870383
    [Abstract] [Full Text] [Related]

  • 7. Role of the Egami Score in Predicting Intravenous Immunoglobulin Resistance in Kawasaki Disease Among Different Ethnicities.
    Loomba RS, Raskin A, Gudausky TM, Kirkpatrick E.
    Am J Ther; 2016 Apr 15; 23(6):e1293-e1299. PubMed ID: 25611359
    [Abstract] [Full Text] [Related]

  • 8. Serum Tenascin-C as a Novel Predictor for Risk of Coronary Artery Lesion and Resistance to Intravenous Immunoglobulin in Kawasaki Disease　- A Multicenter Retrospective Study.
    Okuma Y, Suda K, Nakaoka H, Katsube Y, Mitani Y, Yoshikane Y, Ichida F, Matsushita T, Shichino H, Shiraishi I, Abe J, Hiroe M, Yoshida T, Imanaka-Yoshida K.
    Circ J; 2016 Oct 25; 80(11):2376-2381. PubMed ID: 27746411
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of laboratory predictors for intravenous immunoglobulin resistance and coronary artery aneurysm in Kawasaki Disease before and after therapy.
    Liu J, Ye B, Su D, Qin S, Zhao W, Pang Y.
    Clin Rheumatol; 2023 Jan 25; 42(1):167-177. PubMed ID: 36129563
    [Abstract] [Full Text] [Related]

  • 10. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.
    Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, Matsuishi T.
    J Pediatr; 2006 Aug 25; 149(2):237-40. PubMed ID: 16887442
    [Abstract] [Full Text] [Related]

  • 11. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC, Liang CD, Wang CL, Yu HR, Hwang KP, Yang KD.
    Acta Paediatr; 2010 Oct 25; 99(10):1578-83. PubMed ID: 20491705
    [Abstract] [Full Text] [Related]

  • 12. [Expression of sICAM-1 in children with intravenous immunoglobulin-resistant Kawasaki disease].
    Liu F, Ding Y, Yin W.
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec 25; 15(12):1109-12. PubMed ID: 24342209
    [Abstract] [Full Text] [Related]

  • 13. Sonographic gallbladder abnormality is associated with intravenous immunoglobulin resistance in Kawasaki disease.
    Chen CJ, Huang FC, Tiao MM, Huang YH, Lin LY, Yu HR, Yang KD, Huang YC, Chen CC, Chang WC, Kuo HC.
    ScientificWorldJournal; 2012 Dec 25; 2012():485758. PubMed ID: 22792043
    [Abstract] [Full Text] [Related]

  • 14. Neutrophil percentage-to-albumin ratio is a potential marker of intravenous immunoglobulin resistance in Kawasaki disease.
    Deng L, Wang T, Duan Y, Liu B, Jiang J, Liu D, Li G.
    Sci Rep; 2024 Jul 02; 14(1):15232. PubMed ID: 38956281
    [Abstract] [Full Text] [Related]

  • 15. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.
    Ye Q, Gong FQ, Shang SQ, Hu J.
    Clin Immunol; 2016 Oct 02; 171():25-31. PubMed ID: 27519954
    [Abstract] [Full Text] [Related]

  • 16. Predicting IVIG resistance in UK Kawasaki disease.
    Davies S, Sutton N, Blackstock S, Gormley S, Hoggart CJ, Levin M, Herberg JA.
    Arch Dis Child; 2015 Apr 02; 100(4):366-8. PubMed ID: 25670405
    [Abstract] [Full Text] [Related]

  • 17. Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease.
    Tsujimoto H, Takeshita S, Nakatani K, Kawamura Y, Tokutomi T, Sekine I.
    Clin Immunol; 2002 May 02; 103(2):161-8. PubMed ID: 12027421
    [Abstract] [Full Text] [Related]

  • 18. Verification of risk scores to predict i.v. immunoglobulin resistance in incomplete Kawasaki disease.
    Kanamitsu K, Kakimoto H, Shimada A, Nakata Y, Ochi H, Watanabe H, Iwasaki Y, Tokorodani C, Kanazawa A, Maruyama H, Miyazawa M, Nishiuchi R, Kikkawa K.
    Pediatr Int; 2016 Feb 02; 58(2):146-51. PubMed ID: 26190225
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
    Arthritis Rheum; 2013 Mar 02; 65(3):805-14. PubMed ID: 23440694
    [Abstract] [Full Text] [Related]

  • 20. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease.
    Guo MM, Tseng WN, Ko CH, Pan HM, Hsieh KS, Kuo HC.
    Allergy; 2015 Mar 02; 70(3):310-8. PubMed ID: 25585854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.